The President's Working Group on Financial Markets (PWG) on November 14, 2008, announced a series of initiatives to strengthen the oversight and infrastructure of the over-the-counter (OTC) derivatives market.
The initiatives announced last week include the accelerated development of centralized credit default swap (CDS) counterparties, the signing of a Memorandum of Understanding among the Federal Reserve Board of Governors, the Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC) with respect to CDS central counterparties, and broad policy objectives to guide ongoing efforts to address the current challenges associated with OTC derivatives. The PWG also issued a progress summary to provide an overview of the results of ongoing efforts to strengthen the infrastructure of OTC derivatives markets. For the announcement, click here.
Development of CDS Central Counterparties
The PWG has stated that the successful implementation of central counterparty services for credit default swaps is its primary OTC derivatives priority for the purpose of reducing the systemic risk associated with counterparty credit exposures.
Several potential central counterparties (e.g., a clearing house or exchange) have agreed to accelerate the development of their efforts. The relevant regulatory authorities are assessing these central counterparty proposals by conducting detailed on-site reviews of risk management and other key design elements. After completing the on-site reviews, regulators expect to expedite the process of regulatory approvals and/or exemptions and anticipate that one or more CDS central counterparties will commence operations before the end of 2008.
Memorandum of Understanding Among the CFTC, SEC and Federal Reserve
The Board of Governors of the Federal Reserve System, the Securities and Exchange Commission and the Commodity Futures Trading Commission have signed a Memorandum of Understanding in order to facilitate the regulatory approval process and to promote more consistent regulatory oversight. The Memorandum of Understanding establishes a framework for consultation and information sharing on issues related to the CDS central counterparties.
PWG's Policy Objectives for OTC Derivatives
The PWG announced a set of additional policy objectives to guide efforts to address the market challenges associated with OTC derivatives, consistent with the April 2008 recommendations of the Financial Stability Forum1. These policy objectives are intended to be broader than the PWG’s previous OTC derivatives recommendations in the March 13 PWG Policy Statement on Financial Market Developments.
The PWG policy objectives are as follows:
- Improve the transparency and integrity of the credit default swaps market;
- Enhance risk management of OTC derivatives;
- Further strengthen the OTC derivatives market infrastructure; and
- Strengthen cooperation among regulatory authorities.
The PWG stated that the agencies represented by the PWC will work with other regulators and market participants to achieve the stated goals over the next several months and, where necessary, will support legislative change.
President’s Working Group
The PWG was created by Executive Order 12631, signed on March 18, 1988, by U.S. President Ronald Reagan. The Group was established explicitly in response to events in the financial markets surrounding October 19, 1987 (Black Monday), to give recommendations for legislative and private sector solutions for “enhancing the integrity, efficiency, orderliness, and competitiveness of [U.S.] financial markets and maintaining investor confidence.”
The PWG consists of the Secretary of the Treasury, or his designee (as Chairman of the Working Group); the Chairman of the Board of Governors of the Federal Reserve System, or his designee; the Chairman of the Securities and Exchange Commission, or his designee; and the Chairman of the Commodity Futures Trading Commission, or his designee. The PWG, working with the Office of the Comptroller of the Currency and the Federal Reserve Bank of New York, has been actively overseeing improvements underway in OTC derivatives markets.